RESUMO
End stage renal disease (ESRD) population account for 1.9 per patient year of hospital admissions annually. ESRD population are at increased risk of bleeding secondary to use of anticoagulation during hemodialysis and uremia induced platelet dysfunction. Gastrointestinal bleeding accounts for 3-7% of all deaths in ESRD population. Lower gastrointestinal bleeding refers to blood loss from a site in the gastrointestinal tract distal to the ligament of Treitz. It is usually suspected when a patient complains of hematochezia. It is different from patients presenting with hematemesis that suggests bleeding from upper gastrointestinal tract. Common causes of lower gastrointestinal bleed include diverticulosis, ischemia, hemorrhoids, neoplasia, angiodysplasia, and inflammatory bowel disease. ESRD patients are known to retain phosphate alone or in combination with calcium which has been associated with high mortality. Sevelamer is a phosphate binder used widely in ESRD population. The known side effects of sevelamer include metabolic acidosis, vomiting, nausea, diarrhea, dyspepsia, abdominal pain, constipation, flatulence, fecal impaction, and skin rash. We are reporting a unique case of a 56-year-old female with end stage renal disease on sevelamer hydrochloride who presented with gastrointestinal bleeding and underwent a right hemicolectomy found to have sevelamer-induced mucosal ulceration and crystal deposition in the colonic mucosa. This case report highlights the fact that, with widespread use of this medication in the patients with chronic kidney diseases, physicians should be aware of this underrecognized entity in the differential diagnosis of gastrointestinal bleed in ESRD patients.
RESUMO
Renal transplant recipients are prone to develop drug toxicities because of polypharmacy and drug-drug interactions. Colchicine is often used for the treatment of gout in these patients as nonsteroidal medications are contraindicated. In addition, patients are often on corticosteroids and frequent, periodic, dose escalation for gouty flare may lead to side effects. Colchicine-induced myopathy has been very well described in the literature. Several cases of colchicine toxicity have been reported in cyclosporine-treated patients due to a drug-drug interaction. We report a 62-year-old African American renal transplant recipient who had been doing well on tacrolimus-based immunosuppression and was started on colchicine (0.6 mg twice daily) for gouty flare. A few days later, he was found to have a 4-fold increase in aspartate aminotransferase and an elevated creatine phosphokinase. Although this interaction is very well known with cyclosporine, it has not yet been reported in patients on tacrolimus.
Assuntos
Colchicina/efeitos adversos , Imunossupressores/uso terapêutico , Transplante de Rim , Doenças Musculares/induzido quimicamente , Tacrolimo/uso terapêutico , Interações Medicamentosas , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Patients with nephrotic syndrome, particularly those with membranous nephropathy tend to be in a hypercoagulable state and often present with thromboembolic phenomena. The association of nephrotic syndrome with a bleeding diathesis however is much less common and the etiologies less well recognized. We report a patient who presented with coagulopathy and recurrent spontaneous hemorrhage in association with nephrotic syndrome. The case highlights key diagnostic and therapeutic challenges and strategies: 1) work up to establish a unifying etiology for both nephrotic syndrome and the bleeding disorder; 2) decision making to obtain a tissue biopsy, select the site of biopsy and understand the relative yields for each site; 3) recognizing the risk and managing peri-procedural bleeding; and 5) developing a treatment strategy with the lowest risk of possible complications. Our patient underwent a kidney biopsy without any complications and a definitive diagnosis of AL amyloidosis was reached. He was treated with anti-plasma cell chemotherapy followed by autologous stem cell transplant with resultant complete hematologic response, improved coagulation parameters, and no further bleeding.
Assuntos
Transtornos da Coagulação Sanguínea/etiologia , Hemorragia/etiologia , Síndrome Nefrótica/sangue , Adulto , Humanos , Masculino , Síndrome Nefrótica/patologiaRESUMO
Krokodil (also known as crocodile, croc, krok, and poor man's heroin) is a suspension of desomorphine as the core substance with contaminants like iodide, phosphorous, and heavy metals, which are the byproducts of the manufacturing process. The name krokodil emerged due to the appearance of the skin lesions around the injection site, where it turns green and scaly like a crocodile skin due to desquamation. It is also known as the "drug that eats junkies" and "Russia's Designer drug." It is not available as a prescription anywhere in the world. It is a modern day man-made Frankenstein-like drug, which was manufactured due to the pursuit of drug addicts to make a cheap yet effective narcotic but ended up in creating havoc on its users. It has devastating effects on its users, including damage to skin, blood vessels, muscles, bones, and sometimes even multiorgan failure and eventually death. A systemic review was conducted to obtain any available data for the term krokodil to collect information for this article.
Assuntos
Codeína/análogos & derivados , Drogas Ilícitas/farmacologia , Codeína/efeitos adversos , Codeína/farmacologia , Humanos , Drogas Ilícitas/efeitos adversosRESUMO
We report a very rare case of acute pyelonephritis in a 51-year-old female with a history of chronic kidney disease (CKD) and diabetes caused by a normally benign and a well-known human commensal organism, Saccharomyces cerevisiae that is very often prescribed as a probiotic in modern medical practice. The causal role of S. cerevisiae was confirmed by its isolation in blood, urine, stool as well as vaginal swabs thus proving its virulent nature in suitable situations.
Assuntos
Micoses/microbiologia , Pielonefrite/microbiologia , Saccharomyces cerevisiae/patogenicidade , Infecções Urinárias/microbiologia , Doença Aguda , Antifúngicos/uso terapêutico , Fezes/microbiologia , Feminino , Fungemia/diagnóstico , Fungemia/tratamento farmacológico , Fungemia/microbiologia , Humanos , Pessoa de Meia-Idade , Micoses/sangue , Micoses/diagnóstico , Micoses/tratamento farmacológico , Micoses/urina , Pielonefrite/sangue , Pielonefrite/diagnóstico , Pielonefrite/tratamento farmacológico , Pielonefrite/urina , Saccharomyces cerevisiae/efeitos dos fármacos , Saccharomyces cerevisiae/isolamento & purificação , Resultado do Tratamento , Infecções Urinárias/sangue , Infecções Urinárias/diagnóstico , Infecções Urinárias/tratamento farmacológico , Infecções Urinárias/urina , Vagina/microbiologia , VirulênciaRESUMO
Propylene glycol toxicity presenting as high anion gap metabolic acidosis and osmolar gap has been extensively reported in literature, and most of them are secondary to intravenous lorazepam infusion. However, propylene glycol is used as a solvent in a number of medications that are frequently utilized in critical care setting, and hence one should be aware that the toxicity is possible from a variety of medication. Phenobarbital and phenytoin are one of those, and we hereby report a novel case of propylene glycol toxicity secondary to phenobarbital and phenytoin infusion in a patient with refractory status epilepticus. Furthermore, our patient had end-stage renal disease, which we think could have been an important precipitating factor for the toxicity. Because most of the symptoms from propylene glycol toxicity can mimic sepsis-which is very common in critical care unit patients-this life threatening scenario could be easily missed. Regular monitoring of osmolar gap is an easily available intervention in the at risk patients.
Assuntos
Acidose/induzido quimicamente , Falência Renal Crônica/complicações , Propilenoglicol/efeitos adversos , Solventes/efeitos adversos , Anticonvulsivantes/administração & dosagem , Anticonvulsivantes/uso terapêutico , Feminino , Humanos , Pessoa de Meia-Idade , Concentração Osmolar , Fenobarbital/administração & dosagem , Fenobarbital/uso terapêutico , Fenitoína/administração & dosagem , Fenitoína/uso terapêutico , Propilenoglicol/química , Solventes/química , Estado Epiléptico/tratamento farmacológicoRESUMO
Immunoglobulin (Ig) A nephropathy is one of the most common causes of glomerulonephritis worldwide. Its prognosis can be totally different in various patient populations, ranging from asymptomatic slow progression to end-stage renal disease in as much as 40% of patients in few months to years. This disease process can be idiopathic, or it can be associated with a variety of disease processes. Various risk stratification scoring systems are available, which can predict the long-term outcome. New evidences are also emerging that IgA nephropathy is an autoimmune disease with a known antigen, galactose-deficient IgA1, which can elicit an autoantibody response and formation of immune complexes that are deposited in the mesangium.
Assuntos
Glomerulonefrite por IGA/etiologia , Glomerulonefrite por IGA/diagnóstico , Humanos , PrognósticoAssuntos
Síndrome de ACTH Ectópico/etiologia , Antineoplásicos/efeitos adversos , Cisplatino/efeitos adversos , Túbulos Renais/efeitos dos fármacos , Síndrome de Cushing/etiologia , Feminino , Humanos , Hipopotassemia/induzido quimicamente , Neoplasias Pulmonares/complicações , Neoplasias Pulmonares/tratamento farmacológico , Magnésio/sangue , Pessoa de Meia-Idade , Carcinoma de Pequenas Células do Pulmão/complicações , Carcinoma de Pequenas Células do Pulmão/tratamento farmacológicoAssuntos
Drogas Desenhadas , Dependência de Heroína/complicações , Úlcera da Perna/induzido quimicamente , Dependência de Morfina/complicações , Derivados da Morfina/síntese química , Abuso de Substâncias por Via Intravenosa/complicações , Adulto , Codeína , Humanos , Úlcera da Perna/patologia , Úlcera da Perna/terapia , Masculino , Necrose , Federação Russa , Estados UnidosRESUMO
Tunneled hemodialysis catheters are well-documented causes of benign central vein stenosis, which can be associated with proximal or downhill esophageal varices due to shunting of blood flow from the upper portion of the body through the esophageal venous plexuses. A majority of these cases remain asymptomatic. As a result, studies are largely limited to symptomatic patients, with incidence rates ranging from 16% to 29%. Recently, Hemodialysis Reliable Outflow (HeRO) graft has been introduced as an effective alternate hemodialysis access in catheter-dependent patients, especially in the presence of significant central venous occlusion. It differs from a conventional arteriovenous graft (AVG) by the fact that its venous outflow end is in the right atrium via one of the central veins, bypassing any significant occlusion upstream. Lower intervention rates and reduced incidence of bacteremia make it comparable to conventional tunneled catheters. However, the incidence of central vein occlusion and associated complications with HeRO grafts is unknown. We present the first case of gastrointestinal bleeding from downhill esophageal varices secondary to HeRO-graft-related SVC occlusion.
Assuntos
Varizes Esofágicas e Gástricas/etiologia , Hemorragia Gastrointestinal/etiologia , Falência Renal Crônica/terapia , Diálise Renal/efeitos adversos , Síndrome da Veia Cava Superior/complicações , Dispositivos de Acesso Vascular/efeitos adversos , Enxerto Vascular/métodos , Idoso , Varizes Esofágicas e Gástricas/diagnóstico , Humanos , Masculino , Síndrome da Veia Cava Superior/diagnóstico , Enxerto Vascular/efeitos adversosRESUMO
Hyperammonemia is a metabolic derangement that can be potentially fatal. Primary hyperammonemia due to urea cycle enzyme deficiency is usually discovered in neonates but rarely can present in adulthood. Late-onset manifestations of urea cycle disorders can go unnoticed, until they become life threatening. The authors report a 28-year-old man who developed hyperammonemia in the hospital following parenteral nutrition (PN), leading to cerebral edema, which was fatal despite resolution of the hyperammonemia with cessation of PN and the use of continuous renal replacement therapy.
Assuntos
Amônia/sangue , Edema Encefálico/etiologia , Proteínas Alimentares/sangue , Hiperamonemia/etiologia , Nutrição Parenteral/efeitos adversos , Distúrbios Congênitos do Ciclo da Ureia/complicações , Adulto , Evolução Fatal , Humanos , Hiperamonemia/sangue , Masculino , Diálise Renal , Insuficiência Renal , Distúrbios Congênitos do Ciclo da Ureia/enzimologiaAssuntos
Anti-Inflamatórios/efeitos adversos , Anticorpos Monoclonais/efeitos adversos , Doença de Crohn/tratamento farmacológico , Pericardite/induzido quimicamente , Anti-Inflamatórios/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Doença de Crohn/complicações , Humanos , Infliximab , Masculino , Pessoa de Meia-Idade , Pericardite/diagnósticoRESUMO
Aortic intramural hematoma (IMH) is related to but is pathologically distinct from aortic dissection. In this potentially lethal entity, there is hemorrhage into the aortic media in the absence of an intimal tear. With recent advances in imaging techniques, IMH is now increasingly recognized. The limited data available suggest that the clinical course of IMH mimics that of acute aortic dissection, and mortality rates are similar. Physicians need to be cognizant regarding this entity when they are evaluating chest pain. Here we report a case of IMH, in a 63-year-old female, which was managed conservatively.
RESUMO
Capillary hemangiomas, hamartomatous proliferation of vascular endothelial cells, are rare in the central nervous system (CNS). Intracranial capillary hemangiomas presenting with reversible behavioral abnormalities and focal neurological deficits have rarely been reported. We report a case of CNS capillary hemangioma presenting with transient focal neurological deficits and behavioral abnormalities mimicking Ganser's syndrome. Patient underwent total excision of the vascular malformation, resulting in complete resolution of his symptoms.
RESUMO
The risk of venous thromboembolism (VTE) in patients with Neuroleptic malignant syndrome (NMS) and those on antipsychotic medications is well established. We present here a case whereby the patient had NMS and developed extensive deep venous thrombosis (DVT) despite being on standard DVT Prophylaxis. Our case illustrates that empiric intravenous heparin for the initial few days after the onset of NMS may be considered in those with high risk of VTE, as in such patients standard DVT prophylaxis may not be sufficient. To standardize as to which patients with NMS would be at the highest risk of VTE while on standard DVT prophylaxis, the role of a standardized scoring system and a double-blind randomized trial in the future would probably be beneficial.
RESUMO
Percutaneous mechanical thrombectomy (PMT) has been gaining acceptance as a preferred approach for the treatment of acute deep venous thrombosis (DVT). In addition to treating acute DVT and decreasing the risk of pulmonary embolism, it has been reported that direct extraction of the thrombus decreases the risk of post-thrombotic syndrome (PTS), the economic impact of managing which is reported to account for 75% of the total cost of management of DVT patients. PMT combines localized thrombolysis with mechanical thrombectomy. Recently, there have been some reports of reversible acute kidney injury (AKI) occurring post-PMT. The pathophysiology of AKI in such cases is due to hemoglobinuria-associated acute tubular necrosis. Therefore, the overall prognosis of AKI post-PMT has been reported to be good. We report here a case of AKI post-PMT for an extensive DVT of the lower extremity whereby the patient continues to require HD even 5 months after the procedure. The patient had normal renal function prior to the procedure and evidence of hemoglobinuria at the time of diagnosis of AKI. Our case illustrates that patients with a large thrombus load may develop severe AKI post-PMT thus requiring hemodialysis for an extended period of time. Limiting the length of time that the mechanical thrombectomy is performed and quantifying the amount of effluent obtained would appear to be a prudent practice to reduce the risks of renal failure. However, no specific guidelines exist as for the limits of hemolysed exudates to be collected.
RESUMO
Isolated spontaneous dissection of renal arteries or its branches are extremely rare. Most cases of renal artery dissection are associated with underlying pathology of the renal arteries. We report a case of spontaneous dissection of the left main renal artery and infarction of the left kidney with positive antiphospholipid antibody. Extensive work up of the patient including imaging studies confirmed the diagnosis of SRAD. Antiphospholipid antibodies may have a role in the pathogenesis of arterial dissection by causing endothelial dysfunction. This is a first literature report.